AKT1 and breast carcinoma: This is not surprising, as many downstream growth factors activate PI-3K/AKT and MAPK-ERK1/2 signaling, and FASN activation therefore overlaps with phenotypic traits observed in breast cancer cell lines that overexpress HER2 [25,26,27,28,29].